Skip to main content
. 2013 Aug 14;8(8):e71844. doi: 10.1371/journal.pone.0071844

Table 1. Study design to investigate CWD vertical/maternal transmission.

Offspring cohort Dam’s CWD status Dam # Offspring # Dam’s clinical disease stage (cohort) Offspring gestational stage
Full term viable Positive 11* 242 Late (2) Full term
45 531 Late (2) Full term
46 551 Early (1) Full term
Negative 16 201 NCD (3) Full term
16 222 NCD (3) Full term
19 211 NCD (3) Full term
19 262 NCD (3) Full term
Full term nonviable Positive 11* 231 Early (1) Full term
50 541 Early (1) Full term
15 251 Late (2) Full term
47 511 Late (2) Full term
44 521 Late (2) Full term died 10 dpb
43 561 Late (2) Full term died 2 dpb
Negative 16 273 NCD (3) Full term died 5 dpb
In utero harvest Positive 47 572 Late (2) Late gestation
45 582 Late (2) Late gestation
50 592 Late (2) Early gestation
Negative 64 801 NCD (3) Early gestation
*

Dam inoculated orally (PO) only. All other dams inoculated PO and subcutaneously (SC).

Late = > ½ time to dam terminal TSE disease.

Early = < ½ time to dam terminal TSE disease.

Late gestation = >3.5 months gestation.

Early gestation = <3.5 months gestation.

NCD = No clinical disease.

dpb = days post birth.

1

Dam’s first conception.

2

Dam’s second conception.

3

Dam’s third conception.